Finally, baseline WAT mRNA expressions of NLRP3 or IL1B were associated with systemic risk factors for T2D and markers of WAT inflammation and dysfunction without a group-difference (Supplementary Fig S5). This evidence concerns the gene IL1B and type 2 diabetes mellitus.